Strategy for modular assembly of tetravalent, multispecific antibodies
Protein Science · 2026-10 · 35 (10)
DOI: 10.1002/pro.70797 ↗At a glance
Journal article in Protein Science, published online on 2026-09-18. Written by Evan Mallette and 12 co-authors. Institution: The Anvil Institute of Systems Biologics, Toronto, Ontario, Canada. Major MEDLINE topics: Antibodies, Bispecific, B7-H1 Antigen, Immunoglobulin Fab Fragments. Cited 1 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIGMS NIH HHS, Aarvik Therapeutics, Simisco Biosciences.
Abstract (original language)
Multispecific, multivalent antibodies (Abs) are a burgeoning class of drugs that dramatically expand the pharmacological repertoire beyond traditional therapeutic Abs. Here, we present a simple, modular approach to developing multispecific, multivalent Abs based on a Fab‐phage library with a single light chain. Using this library, we created three Abs targeting unique sites on programmed death‐ligand 1 (PD‐L1) and another antibody targeting CD30. Biophysical and cellular characterization of these Abs demonstrated their functional equivalence to clinically relevant Abs targeting PD‐L1 or CD30. We then combined these paratopes into a series of bispecific, tetravalent, triparatopic Abs that retained the functionality of the parental Abs. Structural analysis of each of the Abs in complex with their cognate antigens demonstrated the adaptability of the common light chain to form diverse paratopes with an array of distinct heavy chains.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- The Anvil Institute of Systems Biologics, Toronto, Ontario, Canada.
- Department of Chemistry and Biochemistry, Wilfrid Laurier University, Waterloo, Ontario, Canada.
- Aarvik Therapeutics, Hayward, California, USA.
- Simisco Biosciences, Hayward, California, USA.
ORCID profiles: Levi L Blazer, Craig A Hokanson, Sunil Bhakta, Jagath R Junutula, Jarrett J Adams
Funding
- NIGMS NIH HHS
- Aarvik Therapeutics
- Simisco Biosciences
- DOE Office of Biological and Environmental Research
- NIH HHS
- National Institute of General Medical Sciences (NIGMS)
- National Institutes of Health
Cite
APA
Mallette, E., Blazer, L. L., Hokanson, C. A., Chen, C., Perez, J. G., Pavlenco, A., Ploder, L., Singer, A. U., Suits, M. D. L., Bhakta, S., Junutula, J. R., Adams, J. J., & Sidhu, S. S. (2026). Strategy for modular assembly of tetravalent, multispecific antibodies. Protein Science, 35(10). https://doi.org/10.1002/pro.70797
Vancouver
Mallette E, Blazer LL, Hokanson CA, Chen C, Perez JG, Pavlenco A, et al. Strategy for modular assembly of tetravalent, multispecific antibodies. Protein Science. 2026;35(10). doi:10.1002/pro.70797
BibTeX
@article{Mallette2026,
author = {Mallette, Evan and Blazer, Levi L and Hokanson, Craig A and Chen, Chao and Perez, Julia Garcia and Pavlenco, Alevtina and Ploder, Lynda and Singer, Alexander U and Suits, Michael D L and Bhakta, Sunil and Junutula, Jagath R and Adams, Jarrett J and Sidhu, Sachdev S},
title = {Strategy for modular assembly of tetravalent, multispecific antibodies},
journal = {Protein Science},
year = {2026},
volume = {35},
number = {10},
doi = {10.1002/pro.70797}
}
EUVIMED